$0.21 -0.00 (-0.48%) ImmunoCellular Therapeutics Ltd - NYSE Amex Equities

Jul. 22, 2016 | 04:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 0.21
Trade Time: Jul 22 04:00 PM Eastern Daylight Time
Change: +-0.00 (-0.48%)
Prev Close: 0.21
Open: 0.21
Bid: 0.20
Ask: 0.21
  1. No results found.
  1. ImmunoCellular Therapeutics Presents Updated ICT-107 Phase 2 Survival and Immune Response Data at the Society for Neuro-Oncology Annual Meeting 2015

    Benzinga | Nov. 20, 2015 | 06:01AM EST
  2. ImmunoCellular Announces Update on ICT-107

    Benzinga | Aug. 21, 2015 | 06:05AM EST
  3. ImmunoCellular Therapeutics Letter to Shareholders Highlights Progress on Advancing ICT-107 to Phase 3 Registrational Trial

    Benzinga | Aug. 21, 2015 | 06:04AM EST
  4. Morning Market Gainers

    Benzinga | Aug. 13, 2015 | 09:45AM EST
  5. ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine

    Benzinga | Dec. 17, 2014 | 06:02AM EST
  6. US Stock Futures Down; Crude Oil Tumbles Over 1%

    Benzinga | Dec. 1, 2014 | 07:02AM EST
  7. US Stock Futures Up Ahead Of New Home Sales Report

    Benzinga | Sep. 24, 2014 | 07:20AM EST
  8. 5 Companies Developing New Cancer Drugs

    Benzinga | Aug. 19, 2014 | 13:20PM EST
  9. Morning Movers for Feb. 25, 2014: IMUC, MSO, ZU, CARA, VSI, TSLA, XOMA, BCRX Moving Higher, RP, ODP, VVUS, AINV, MGIC, ALSN Lower

    Benzinga | Feb. 25, 2014 | 09:41AM EST
  10. Morning Market Losers

    Benzinga | Jan. 22, 2014 | 10:29AM EST
  11. Morning Market Movers

    Benzinga | Jan. 21, 2014 | 10:30AM EST
  12. Morning Market Losers

    Benzinga | Dec. 12, 2013 | 09:59AM EST
  13. UPDATE: MLV & Co. Downgrades ImmunoCellular Therapeutics on Negative Outlook for ICT-107

    Benzinga | Dec. 12, 2013 | 08:58AM EST
  14. ImmunoCellular Therapeutics Announces Positive ICT-107 Phase II Study Results

    Benzinga | Dec. 11, 2013 | 16:02PM EST
  15. ImmunoCellular Therapeutics Expands Manufacturing Relationship with Neostem's Progenitor Cell Therapy

    Benzinga | Dec. 3, 2013 | 06:03AM EST
Trading Center